COVID-19 Response: Local Logistics National Effort
Listed below are the Publications supported by Technology platforms at C-CAMP / Bangalore Life Science Cluster.
Export 7 results:Author Title [ Type] Year
Filters: Author is Pal, Rajarshi [Clear All Filters]
Derivation of Induced Pluripotent Stem Cell (iPSC) Lines from Patient-Specific Peripheral Blood Mononuclear Cells (PBMC) Using Episomal Vectors [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. Methods Mol Biol.. 2021.
Differentiating Human Induced Pluripotent Stem Cells (iPSCs) Into Lung Epithelial Cells. [Eyestem, a C-CAMP Startup]. Curr Protoc Stem Cell Biol. :e86.. 2019.
Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD). [Eyestem, a C-CAMP Startup]. Methods Mol Biol.. 2018.
Human induced pluripotent stem cell-derived lung epithelial system for SARS-CoV-2 infection modeling and its potential in drug repurposing [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. Stem Cells Dev.. 2020.
Interventional Strategies for Parkinson Disease: Can Neural Precursor Cells Forge a Path Ahead? [Eyestem Research, a C-CAMP startup] ACS Chemical Neuroscience.. 2021.
SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. J Cell Physiol.. 2022.